Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

SABS

SABS News

Newswire

03:45

Sab Biotherapeutics to Present Data on SAB-142 at ATTD-Asia Conference

08:25

SAB Biotherapeutics presents data on SAB-142 at ATTD-Asia conference.

07:47

SAB Biotherapeutics' Ownership Structure Reveals Individual Investors' Dominance

09:40

SAB Biotherapeutics shares jump 11.71% intraday after reporting $45.4M Q3 net income, driven by warrant liability gains and $168.7M fundraising.

07:17

Chardan Capital Raises SAB Biotherapeutics Buy Rating to $12 from $11.

View More

About SABS

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More